查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1421749

眼科药品市场、份额、规模、趋势、产业分析报告：依药物类别、疾病、给药途径、产品类型、剂型、地区、细分市场预测，2023-2032

Ophthalmic Drug Market Share, Size, Trends, Industry Analysis Report, By Drug Class ; By Disease; By Route of Administration; By Product Type; By Dosage Form; By Region; Segment Forecast, 2023 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 116 Pages | 商品交期: 最快1-2个工作天内

价格

根据Polaris Market Research的最新研究，到2032年，全球眼科药品市场规模预计将达到735.7亿美元。 该报告提供了对当前市场动态的详细见解，并对未来市场成长进行了分析。

眼科治疗在白内障、青光眼、糖尿病视网膜病变、近视脉络膜等多种眼部疾病的治疗中发挥重要作用。 特别是，根据世界卫生组织（WHO）的数据，青光眼是全球第二大失明原因。 市面上提供多种眼科药物，包括头孢唑林、庆大霉素、EDTA 和贝伐珠单抗。 此外，加强医疗基础设施、旨在提高全球健康意识的政府措施以及增加开发先进药物的投资等因素也支持市场成长预期。

由于全球老年人口增加、已开发国家和新兴国家青光眼患者数量增加以及眼部相关疾病的医疗保健支出增加等因素，市场收入份额预计将在预测期内扩大。

眼科药物市场受到 COVID-19 大流行的负面影响。 例如，根据 2021 年 11 月《临床眼科杂誌》报道，对大流行前和大流行后数据的分析发现，眼保健的各个方面均显着下降。 疫情前与疫情后相比，视野检查减少了93.84%，就诊减少了92.52%，药物治疗减少了19.63%，手术减少了72.74%。 这些数据表明，在大流行期间，青光眼和其他眼部疾病的治疗量显着减少。 然而，随着 COVID-19 疫苗的广泛使用以及 COVID-19 病例数的持续下降，预计市场将会復苏。

此外，国家医学图书馆 2021 年 6 月发表的一项研究强调了冠状动脉疾病 (CAD) 对全球健康的重大影响。 据估计，仅 CAD 每年就会导致约 61 万人死亡，占死亡人数的四分之一，使其成为美国的主要原因。 随着 CAD 盛行率的增加，对有效眼科药物设备的需求不断增长，以满足这一紧迫的医疗需求。 因此，预计这一因素将在预测期内推动眼科药物的需求。

眼科药品市场报告重点

2022年，抗发炎领域占据市场主导地位，占据最大的销售份额。 这是由于寻求眼部过敏和发炎治疗的患者数量增加。 同时，抗VEGF领域预计在预测期内将呈现显着的复合年增长率。 这一增长是由视网膜疾病盛行率上升推动的，包括糖尿病视网膜病变和老年黄斑部病变等疾病。 此外，这些疾病在人群中不断增加的诊断率正在推动各个地区对抗 VEGF 治疗的需求。

在整个预测期内，半固体细分市场占据着市场份额。 该细分市场预计将实现更高的复合年增长率（CAGR），主要是由于批准和产品发布的增加。 这些批准包括多种产品，包括软膏、悬浮液和凝胶。 药膏的使用越来越多，特别是在治疗发炎性疾病、感染和干眼症方面，由于其疗效的提高，使其越来越受欢迎。 此外，主要行业进入者为获得批准和推出更广泛的产品而加大力度，进一步推动了该细分市场的成长。

2022年，北美占据最大市场榜首。 这一优势得益于该地区眼病的高盛行率以及公众对这些疾病的认识不断提高。 此外，该行业主要参与者的持续研发努力预计将有助于该地区的进一步成长。 作为额外的好处，北美是Pfizer, Alcon, Bausch & Lomb等大公司的所在地，进一步增强了其市场地位。

目录

第一章简介

第 2 章执行摘要

第三章研究方法

第四章全球眼科药物市场洞察

  • 眼药水 - 产业快照
  • 眼科药物市场动态
    • 推动者和机会
      • 由于临床试验和候选药物的增加，对创新药物和治疗方法的需求不断增加。
      • 隐形眼镜的使用范围扩大
    • 抑制因素和挑战
      • 市场收入成长可能会因专利过期药物或面临审批延迟的药物的供应而受到阻碍
  • 杵分析
  • 眼科製药业的趋势
  • COVID-19 感染的影响分析

第 5 章全球眼科药物市场（依药物类别）

  • 主要调查结果
  • 简介
  • 抗 VEGF 剂
  • 抗青光眼
  • 抗发炎
  • 抗过敏
  • 其他

第 6 章全球眼科药物市场（按疾病）

  • 主要调查结果
  • 简介
  • 青光眼
  • 干眼症
  • 视网膜疾病
  • 眼睛过敏
  • 眼部感染
  • 其他

第七章全球眼科药物市场（依给药途径）

  • 主要调查结果
  • 简介
  • 系统性
  • 本地
  • 局部眼科
  • 结膜下
  • 玻璃体内
  • 视网膜疾病
  • 球后
  • 前房内

第 8 章全球眼科药品市场（依产品类型）

  • 主要调查结果
  • 简介
  • 非处方药
  • 处方药

第9章全球眼科药物市场，按剂型

  • 主要调查结果
  • 简介
  • 半固体
  • 液体
  • 固体

第10章全球眼科药物区域市场

  • 主要调查结果
  • 简介
    • 2019-2032 年眼科药物市场评估（按地区）
  • 眼科药品市场 - 北美
    • 北美：2019-2032 年眼科药物市场（依药物类别）
    • 北美：眼科药品市场（依产品类型），2019-2032 年
    • 北美：眼科药品市场，依疾病分类，2019-2032 年
    • 北美：2019-2032 年眼科药物市场（依给药途径）
    • 北美：2019-2032 年眼科药品市场（按剂型）
    • 眼科药品市场 - 美国
    • 眼科药品市场 - 加拿大
  • 眼科药品市场 - 欧洲
    • 欧洲：2019-2032 年眼科药物市场（依药物类别）
    • 欧洲：眼科药品市场（依产品类型），2019-2032 年
    • 欧洲：眼科药品市场，依疾病分类，2019-2032 年
    • 欧洲：2019-2032 年眼科药物市场（依给药途径）
    • 欧洲：2019-2032 年眼科药品市场（按剂型）
    • 眼科药品市场 - 英国
    • 眼科药品市场 - 法国
    • 眼科药品市场 - 德国
    • 眼科药品市场 - 义大利
    • 眼科药品市场 - 西班牙
    • 眼科药品市场 - 荷兰
    • 眼科药品市场 - 俄罗斯
  • 眼科药品市场 - 亚太地区
    • 亚太地区：2019-2032 年眼科药物市场（依药物类别）
    • 亚太地区：眼科药品市场（依产品类型），2019-2032 年
    • 亚太地区：眼科药品市场，依疾病分类，2019-2032 年
    • 亚太地区：2019-2032 年眼科药物市场（依给药途径）
    • 亚太地区：2019-2032 年眼科药品市场（按剂型）
    • 中国眼科药品市场
    • 眼科药品市场 - 印度
    • 日本眼科药品市场
    • 眼科药品市场 - 马来西亚
    • 印尼眼科药品市场
    • 韩国眼科药品市场
  • 眼科药品市场 - 中东和非洲
    • 中东和非洲：2019-2032 年眼科药物市场（依药物类别）
    • 中东和非洲：2019-2032 年眼科药品市场（依产品类型）
    • 中东和非洲：眼科药品市场，依疾病分类，2019-2032 年
    • 中东和非洲：2019-2032 年眼科药物市场（依给药途径）
    • 中东和非洲：2019-2032 年眼科药品市场（按剂型）
    • 眼科药品市场 - 沙乌地阿拉伯
    • 眼科药品市场 - 阿拉伯联合大公国
    • 眼科药品市场 - 以色列
    • 眼科药品市场 - 南非
  • 眼科药品市场 - 拉丁美洲
    • 拉丁美洲：2019-2032 年眼科药物市场（依药物类别）
    • 拉丁美洲：眼科药品市场（依产品类型），2019-2032 年
    • 拉丁美洲：眼科药品市场，依疾病分类，2019-2032 年
    • 拉丁美洲：2019-2032 年眼科药物市场（依给药途径）
    • 拉丁美洲：2019-2032 年眼科药品市场（按剂型）
    • 眼科药品市场 - 墨西哥
    • 眼科药品市场 - 巴西
    • 眼科药品市场 - 阿根廷

第十一章竞争态势

  • 扩张与收购分析
    • 放大
    • 收购
  • 伙伴关係/协作/协议/揭露

第十二章公司简介

  • Alcon
  • Allergan（AbbVie Inc）
  • Bausch Health Companies Inc.
  • Bayer AG
  • Coherus Biosciences, Inc.
  • Genentech, Inc.（F. Hoffmann-La Roche Ltd）
  • Merck & Co., Inc
  • Nicox
  • Novartis AG
  • Pfizer Inc.
  • Regeneron Pharmaceuticals Inc
Product Code: PM4073

The global ophthalmic drug market size is expected to reach USD 73.57 billion by 2032, according to a new study by Polaris Market Research. The report "Opthalmic Drug Market Share, Size, Trends, Industry Analysis Report, By Drug Class (Anti-VEGF Agents, Anti-glaucoma, Anti-inflammatory, Antiallergy, Others); By Disease; By Route of Administration; By Product Type; By Dosage Form; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Ophthalmic drugs play a crucial role in the treatment of a range of eye diseases, including cataracts, glaucoma, diabetic retinopathy, myopic choroidal, and others. Notably, glaucoma, according to the World Health Organization (WHO), stands as the second leading cause of blindness worldwide. The market offers a variety of ophthalmology medications, such as cefazolin, gentamicin, EDTA, bevacizumab, and more. Furthermore, the anticipation of market growth is bolstered by factors such as enhanced healthcare infrastructure, government initiatives aimed at raising global health awareness, and increased investments in the development of advanced drug types.

The market revenue share is expected to grow during the forecast period due to factors like the increasing global elderly population, a rising number of glaucoma patients in both developed and developing countries, and higher healthcare spending on eye-related diseases.

The ophthalmic drugs market experienced adverse effects due to the COVID-19 pandemic. For instance, as reported in the Clinical Ophthalmology Journal in November 2021, an analysis of data from pre-pandemic and post-pandemic periods revealed a substantial decline in various aspects of eye care. Visual field checkups, clinical visits, medication releases, and surgical procedures saw reductions of 93.84%, 92.52%, 19.63%, and 72.74% when comparing the pre-pandemic and post-pandemic times. This data indicates a significant decrease in the treatment of glaucoma and other ophthalmic disorders during the pandemic. However, the market is expected to rebound as COVID-19 vaccines become widely available and the number of COVID-19 cases continues to decline.

Additionally, a study published in the National Library of Medicine in June 2021 highlighted the significant impact of coronary artery disease (CAD) on global health. CAD alone is responsible for approximately 610,000 deaths annually, accounting for an estimated one in four deaths and making it the foremost cause of mortality in the United States. With the incidence of CAD rising, there is a growing demand for effective Opthalmic Drug devices to address this pressing medical need. Consequently, this factor is projected to drive the demand for Opthalmic Drugs throughout the forecast period.

Opthalmic Drug Market Report Highlights

In 2022, the Anti-inflammatory segment dominated the market, capturing the largest share of revenue. This can be attributed to the increasing number of patients seeking treatment for ocular allergies and inflammation. Concurrently, the Anti-VEGF segment is expected to show a significant CAGR over the forecast period. This growth is propelled by the escalating prevalence of retinal disorders, including conditions like diabetic retinopathy and age-related macular degeneration, among others. Furthermore, the rising rate of diagnosis for these conditions within the population is fueling the demand for anti-VEGF therapy across various regions.

The Semisolid segment dominated the market share throughout the forecast period. This segment is anticipated to achieve a higher Compound Annual Growth Rate (CAGR), mainly due to the increasing number of approvals and product launches. These approvals encompass a range of products, including ointments, suspensions, gels, and others. The growing utilization of ointments, particularly in the treatment of inflammatory conditions, infections, and dry eye, has contributed to their rising popularity due to their enhanced effectiveness. Furthermore, the segment's growth is further propelled by the intensified efforts of key industry players to secure approvals and introduce a wider array of products.

In 2022, North America held the top position as the largest market. This dominance is influenced by a higher prevalence of eye diseases in the region and an increasing awareness of these conditions among the population. Moreover, the continuous research and development endeavors by key industry players are anticipated to contribute to the further growth of the region. Additionally, North America benefits from the presence of major players such as Pfizer Inc., Alcon, and Bausch and Lomb, which further bolster its market position.

The global key market players include: es, Inc., Genentech, Inc. (F. Hoffmann-La Roche Ltd), Merck & Co., Inc., Nicox, Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc.

Polaris Market Research has segmented the Opthalmic Drug market report based on disease, drug class, route of administration, dosage form, product type, and region:

Opthalmic Drug, Disease Outlook (Revenue - USD Billion, 2019 - 2032)

  • Glaucoma
  • Dry Eye
  • Retinal Disorders
  • Eye Allergy
  • Eye Infection
  • Others

Opthalmic Drug, Drug Class Outlook (Revenue - USD Billion, 2019 - 2032)

  • Anti-VEGF Agents
  • Anti-glaucoma
  • Anti-inflammatory
  • Steroidal drugs
  • Non-steroidal drugs
  • Antiallergy
  • Others

Opthalmic Drug, Route of Administration Outlook (Revenue - USD Billion, 2019 - 2032)

  • Systemic
  • Topical
  • Local Ocular
  • Subconjunctival
  • Intravitreal
  • Retinal Disorders
  • Retrobulbar
  • Intracameral

Opthalmic Drug, Dosage Form Outlook (Revenue - USD Billion, 2019 - 2032)

  • OTC Drugs
  • Prescription Drugs

Opthalmic Drug, Product Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Semisolid
  • Liquid
  • Solid

Opthalmic Drug, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Ophthalmic Drug Market Insights

  • 4.1. Ophthalmic Drug - Industry Snapshot
  • 4.2. Ophthalmic Drug Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Propelled by increasing clinical trials and pipeline candidates, demand for innovative drugs and therapies is on the rise
      • 4.2.1.2. Growing utilization of contact lenses
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. The growth in market revenue is likely to be hampered by the availability of drugs without patents and those facing delayed approval
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Ophthalmic Drug Industry Trends
  • 4.6. COVID-19 Impact Analysis

5. Global Ophthalmic Drug Market, by Drug Class

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • 5.3. Anti-VEGF Agents
    • 5.3.1. Global Ophthalmic Drug Market, by Anti-VEGF Agents, by Region, 2019-2032 (USD Billion)
  • 5.4. Anti-glaucoma
    • 5.4.1. Global Ophthalmic Drug Market, by Anti-glaucoma, by Region, 2019-2032 (USD Billion)
  • 5.5. Anti-inflammatory
    • 5.5.1. Global Ophthalmic Drug Market, by Anti-inflammatory, by Region, 2019-2032 (USD Billion)
    • 5.5.2. Steroidal drugs
      • 5.5.2.1. Global Ophthalmic Drug Market, by Steroidal drugs, by Region, 2019-2032 (USD Billion)
    • 5.5.3. Non-steroidal drugs
      • 5.5.3.1. Global Ophthalmic Drug Market, by Non-steroidal drugs, by Region, 2019-2032 (USD Billion)
  • 5.6. Antiallergy
    • 5.6.1. Global Ophthalmic Drug Market, by Antiallergy, by Region, 2019-2032 (USD Billion)
  • 5.7. Others
    • 5.7.1. Global Ophthalmic Drug Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Ophthalmic Drug Market, by Disease

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  • 6.3. Glaucoma
    • 6.3.1. Global Ophthalmic Drug Market, by Glaucoma, by Region, 2019-2032 (USD Billion)
  • 6.4. Dry Eye
    • 6.4.1. Global Ophthalmic Drug Market, by Dry Eye, by Region, 2019-2032 (USD Billion)
  • 6.5. Retinal Disorders
    • 6.5.1. Global Ophthalmic Drug Market, by Retinal Disorders, by Region, 2019-2032 (USD Billion)
  • 6.6. Eye Allergy
    • 6.6.1. Global Ophthalmic Drug Market, by Eye Allergy, by Region, 2019-2032 (USD Billion)
  • 6.7. Eye Infection
    • 6.7.1. Global Ophthalmic Drug Market, by Eye Infection, by Region, 2019-2032 (USD Billion)
  • 6.8. Others
    • 6.8.1. Global Ophthalmic Drug Market, by Others, by Region, 2019-2032 (USD Billion)

7. Global Ophthalmic Drug Market, by Route of Administration

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • 7.3. Systemic
    • 7.3.1. Global Ophthalmic Drug Market, by Systemic, by Region, 2019-2032 (USD Billion)
  • 7.4. Topical
    • 7.4.1. Global Ophthalmic Drug Market, by Topical, by Region, 2019-2032 (USD Billion)
  • 7.5. Local Ocular
    • 7.5.1. Global Ophthalmic Drug Market, by Local Ocular, by Region, 2019-2032 (USD Billion)
  • 7.6. Subconjunctival
    • 7.6.1. Global Ophthalmic Drug Market, by Subconjunctival, by Region, 2019-2032 (USD Billion)
  • 7.7. Intravitreal
    • 7.7.1. Global Ophthalmic Drug Market, by Intravitreal, by Region, 2019-2032 (USD Billion)
  • 7.8. Retinal Disorders
    • 7.8.1. Global Ophthalmic Drug Market, by Retinal Disorders, by Region, 2019-2032 (USD Billion)
  • 7.9. Retrobulbar
    • 7.9.1. Global Ophthalmic Drug Market, by Retrobulbar, by Region, 2019-2032 (USD Billion)
  • 7.10. Intracameral
    • 7.10.1. Global Ophthalmic Drug Market, by Intracameral, by Region, 2019-2032 (USD Billion)

8. Global Ophthalmic Drug Market, by Product Type

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  • 8.3. OTC Drugs
    • 8.3.1. Global Ophthalmic Drug Market, by OTC Drugs, by Region, 2019-2032 (USD Billion)
  • 8.4. Prescription Drugs
    • 8.4.1. Global Ophthalmic Drug Market, by Prescription Drugs, by Region, 2019-2032 (USD Billion)

9. Global Ophthalmic Drug Market, by Dosage Form

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Global Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
  • 9.3. Semisolid
    • 9.3.1. Global Ophthalmic Drug Market, by Semisolid, by Region, 2019-2032 (USD Billion)
  • 9.4. Liquid
    • 9.4.1. Global Ophthalmic Drug Market, by Liquid, by Region, 2019-2032 (USD Billion)
  • 9.5. Solid
    • 9.5.1. Global Ophthalmic Drug Market, by Solid, by Region, 2019-2032 (USD Billion)

10. Global Ophthalmic Drug Market, by Geography

  • 10.1. Key findings
  • 10.2. Introduction
    • 10.2.1. Ophthalmic Drug Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 10.3. Ophthalmic Drug Market - North America
    • 10.3.1. North America: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
    • 10.3.2. North America: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
    • 10.3.3. North America: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
    • 10.3.4. North America: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
    • 10.3.5. North America: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
    • 10.3.6. Ophthalmic Drug Market - U.S.
      • 10.3.6.1. U.S.: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
      • 10.3.6.2. U.S.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
      • 10.3.6.3. U.S.: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
      • 10.3.6.4. U.S.: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.3.6.5. U.S.: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
    • 10.3.7. Ophthalmic Drug Market - Canada
      • 10.3.7.1. Canada: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
      • 10.3.7.2. Canada.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
      • 10.3.7.3. Canada: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
      • 10.3.7.4. Canada: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.3.7.5. Canada: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
  • 10.4. Ophthalmic Drug Market - Europe
    • 10.4.1. Europe: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
    • 10.4.2. Europe.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
    • 10.4.3. Europe: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
    • 10.4.4. Europe: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
    • 10.4.5. Europe: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
    • 10.4.6. Ophthalmic Drug Market - UK
      • 10.4.6.1. UK: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
      • 10.4.6.2. UK.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
      • 10.4.6.3. UK: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
      • 10.4.6.4. UK: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.6.5. UK: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
    • 10.4.7. Ophthalmic Drug Market - France
      • 10.4.7.1. France: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
      • 10.4.7.2. France.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
      • 10.4.7.3. France: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
      • 10.4.7.4. France: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.7.5. France: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
    • 10.4.8. Ophthalmic Drug Market - Germany
      • 10.4.8.1. Germany: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
      • 10.4.8.2. Germany.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
      • 10.4.8.3. Germany: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
      • 10.4.8.4. Germany: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.8.5. Germany: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
    • 10.4.9. Ophthalmic Drug Market - Italy
      • 10.4.9.1. Italy: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
      • 10.4.9.2. Italy.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
      • 10.4.9.3. Italy: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
      • 10.4.9.4. Italy: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.9.5. Italy: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
    • 10.4.10. Ophthalmic Drug Market - Spain
      • 10.4.10.1. Spain: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
      • 10.4.10.2. Spain.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
      • 10.4.10.3. Spain: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
      • 10.4.10.4. Spain: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.10.5. Spain: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
    • 10.4.11. Ophthalmic Drug Market - Netherlands
      • 10.4.11.1. Netherlands: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
      • 10.4.11.2. Netherlands.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
      • 10.4.11.3. Netherlands: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
      • 10.4.11.4. Netherlands: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.11.5. Netherlands: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
    • 10.4.12. Ophthalmic Drug Market - Russia
      • 10.4.12.1. Russia: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
      • 10.4.12.2. Russia.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
      • 10.4.12.3. Russia: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
      • 10.4.12.4. Russia: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.12.5. Russia: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
  • 10.5. Ophthalmic Drug Market - Asia Pacific
    • 10.5.1. Asia Pacific: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
    • 10.5.2. Asia Pacific.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
    • 10.5.3. Asia Pacific: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
    • 10.5.4. Asia Pacific: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
    • 10.5.5. Asia Pacific: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
    • 10.5.6. Ophthalmic Drug Market - China
      • 10.5.6.1. China: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
      • 10.5.6.2. China.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
      • 10.5.6.3. China: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
      • 10.5.6.4. China: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.5.6.5. China: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
    • 10.5.7. Ophthalmic Drug Market - India
      • 10.5.7.1. India: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
      • 10.5.7.2. India.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
      • 10.5.7.3. India: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
      • 10.5.7.4. India: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.5.7.5. India: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
    • 10.5.8. Ophthalmic Drug Market - Japan
      • 10.5.8.1. Japan: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
      • 10.5.8.2. Japan.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
      • 10.5.8.3. Japan: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
      • 10.5.8.4. Japan: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.5.8.5. Japan: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
    • 10.5.9. Ophthalmic Drug Market - Malaysia
      • 10.5.9.1. Malaysia: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
      • 10.5.9.2. Malaysia.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
      • 10.5.9.3. Malaysia: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
      • 10.5.9.4. Malaysia: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.5.9.5. Malaysia: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
    • 10.5.10. Ophthalmic Drug Market - Indonesia
      • 10.5.10.1. Indonesia: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
      • 10.5.10.2. Indonesia.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
      • 10.5.10.3. Indonesia: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
      • 10.5.10.4. Indonesia: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.5.10.5. Indonesia: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
    • 10.5.11. Ophthalmic Drug Market - South Korea
      • 10.5.11.1. South Korea: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
      • 10.5.11.2. South Korea.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
      • 10.5.11.3. South Korea: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
      • 10.5.11.4. South Korea: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.5.11.5. South Korea: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
  • 10.6. Ophthalmic Drug Market - Middle East & Africa
    • 10.6.1. Middle East & Africa: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
    • 10.6.2. Middle East & Africa: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
    • 10.6.3. Middle East & Africa: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
    • 10.6.4. Middle East & Africa: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
    • 10.6.5. Middle East & Africa: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
    • 10.6.6. Ophthalmic Drug Market - Saudi Arabia
      • 10.6.6.1. Saudi Arabia: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
      • 10.6.6.2. Saudi Arabia.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
      • 10.6.6.3. Saudi Arabia: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
      • 10.6.6.4. Saudi Arabia: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.6.6.5. Saudi Arabia: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
    • 10.6.7. Ophthalmic Drug Market - UAE
      • 10.6.7.1. UAE: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
      • 10.6.7.2. UAE.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
      • 10.6.7.3. UAE: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
      • 10.6.7.4. UAE: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.6.7.5. UAE: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
    • 10.6.8. Ophthalmic Drug Market - Israel
      • 10.6.8.1. Israel: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
      • 10.6.8.2. Israel.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
      • 10.6.8.3. Israel: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
      • 10.6.8.4. Israel: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.6.8.5. Israel: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
    • 10.6.9. Ophthalmic Drug Market - South Africa
      • 10.6.9.1. South Africa: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
      • 10.6.9.2. South Africa.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
      • 10.6.9.3. South Africa: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
      • 10.6.9.4. South Africa: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.6.9.5. South Africa: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
  • 10.7. Ophthalmic Drug Market - Latin America
    • 10.7.1. Latin America: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
    • 10.7.2. Latin America.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
    • 10.7.3. Latin America: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
    • 10.7.4. Latin America: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
    • 10.7.5. Latin America: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
    • 10.7.6. Ophthalmic Drug Market - Mexico
      • 10.7.6.1. Mexico: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
      • 10.7.6.2. Mexico.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
      • 10.7.6.3. Mexico: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
      • 10.7.6.4. Mexico: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.7.6.5. Mexico: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
    • 10.7.7. Ophthalmic Drug Market - Brazil
      • 10.7.7.1. Brazil: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
      • 10.7.7.2. Brazil.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
      • 10.7.7.3. Brazil: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
      • 10.7.7.4. Brazil: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.7.7.5. Brazil: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
    • 10.7.8. Ophthalmic Drug Market - Argentina
      • 10.7.8.1. Argentina: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
      • 10.7.8.2. Argentina.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
      • 10.7.8.3. Argentina: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
      • 10.7.8.4. Argentina: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.7.8.5. Argentina: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)

11. Competitive Landscape

  • 11.1. Expansion and Acquisition Analysis
    • 11.1.1. Expansion
    • 11.1.2. Acquisitions
  • 11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

  • 12.1. Alcon
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Benchmarking
    • 12.1.4. Recent Development
  • 12.2. Allergan (AbbVie Inc)
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Benchmarking
    • 12.2.4. Recent Development
  • 12.3. Bausch Health Companies Inc.
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Benchmarking
    • 12.3.4. Recent Development
  • 12.4. Bayer AG
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Benchmarking
    • 12.4.4. Recent Development
  • 12.5. Coherus Biosciences, Inc.
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Benchmarking
    • 12.5.4. Recent Development
  • 12.6. Genentech, Inc. (F. Hoffmann-La Roche Ltd)
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Benchmarking
    • 12.6.4. Recent Development
  • 12.7. Merck & Co., Inc
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Benchmarking
    • 12.7.4. Recent Development
  • 12.8. Nicox
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Benchmarking
    • 12.8.4. Recent Development
  • 12.9. Novartis AG
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Benchmarking
    • 12.9.4. Recent Development
  • 12.10. Pfizer Inc.
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Benchmarking
    • 12.10.4. Recent Development
  • 12.11. Regeneron Pharmaceuticals Inc
    • 12.11.1. Company Overview
    • 12.11.2. Financial Performance
    • 12.11.3. Product Benchmarking
    • 12.11.4. Recent Development

List of Tables

  • Table 1 Global Ophthalmic Drug Market, by Drug Class, by Region, 2019-2032 (USD Billion)
  • Table 2 Global Ophthalmic Drug Market, by Disease, by Region, 2019-2032 (USD Billion)
  • Table 3 Global Ophthalmic Drug Market, by Route of Administration, by Region, 2019-2032 (USD Billion)
  • Table 4 Global Ophthalmic Drug Market, by Dosage Form, by Region, 2019-2032 (USD Billion)
  • Table 5 Global Ophthalmic Drug Market, by Product Type, by Region, 2019-2032 (USD Billion)
  • Table 6 North America: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 7 North America: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  • Table 8 North America: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 9 North America: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 10 North America: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  • Table 11 U.S.: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 12 U.S.: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  • Table 13 U.S.: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 14 U.S.: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 15 U.S.: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  • Table 16 Canada: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 17 Canada: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  • Table 18 Canada: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 19 Canada: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 20 Canada: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  • Table 21 Europe: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 22 Europe: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  • Table 23 Europe: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 24 Europe: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 25 Europe: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  • Table 26 Germany: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 27 Germany: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  • Table 28 Germany: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 29 Germany: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 30 Germany: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  • Table 31 France: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 32 France: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  • Table 33 France: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 34 France: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 35 France: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  • Table 36 UK: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 37 UK: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  • Table 38 UK: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 39 UK: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 40 UK: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  • Table 41 Italy: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 42 Italy: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  • Table 43 Italy: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 44 Italy: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 45 Italy: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  • Table 46 Netherlands: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 47 Netherlands: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  • Table 48 Netherlands: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 49 Netherlands: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 50 Netherlands: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  • Table 51 Spain: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 52 Spain: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  • Table 53 Spain: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 54 Spain: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 55 Spain: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  • Table 56 Russia: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 57 Russia: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  • Table 58 Russia: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 59 Russia: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 60 Russia: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  • Table 61 Asia Pacific: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 62 Asia Pacific: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  • Table 63 Asia Pacific: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 64 Asia Pacific: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 65 Asia Pacific: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  • Table 66 China: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 67 China: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  • Table 68 China: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 69 China: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 70 China: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  • Table 71 Japan: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 72 Japan: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  • Table 73 Japan: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 74 Japan: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 75 Japan: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  • Table 76 India: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 77 India: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  • Table 78 India: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 79 India: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 80 India: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  • Table 81 Indonesia: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 82 Indonesia: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  • Table 83 Indonesia: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 84 Indonesia: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 85 Indonesia: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  • Table 86 Malaysia: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 87 Malaysia: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  • Table 88 Malaysia: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 89 Malaysia: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 90 Malaysia: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  • Table 91 South Korea: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 92 South Korea: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  • Table 93 South Korea: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 94 South Korea: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 95 South Korea: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  • Table 96 Latin America: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 97 Latin America: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  • Table 98 Latin America: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 99 Latin America: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 100 Latin America: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  • Table 101 Brazil: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 102 Brazil: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  • Table 103 Brazil: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 104 Brazil: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 105 Brazil: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  • Table 106 Mexico: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 107 Mexico: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  • Table 108 Mexico: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 109 Mexico: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 110 Mexico: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  • Table 111 Argentina: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 112 Argentina: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  • Table 113 Argentina: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 114 Argentina: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 115 Argentina: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  • Table 116 Middle East & Africa: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 117 Middle East & Africa: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  • Table 118 Middle East & Africa: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 119 Middle East & Africa: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 120 Middle East & Africa: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  • Table 121 UAE: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 122 UAE: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  • Table 123 UAE: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 124 UAE: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 125 UAE: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  • Table 126 Saudi Arabia: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 127 Saudi Arabia: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  • Table 128 Saudi Arabia: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 129 Saudi Arabia: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 130 Saudi Arabia: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  • Table 131 South Africa: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 132 South Africa: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  • Table 133 South Africa: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 134 South Africa: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 135 South Africa: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)
  • Table 136 Israel: Ophthalmic Drug Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 137 Israel: Ophthalmic Drug Market, by Disease, 2019-2032 (USD Billion)
  • Table 138 Israel: Ophthalmic Drug Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 139 Israel: Ophthalmic Drug Market, by Dosage Form, 2019-2032 (USD Billion)
  • Table 140 Israel: Ophthalmic Drug Market, by Product Type, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Ophthalmic Drug Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Drug Class
  • Figure 7. Global Ophthalmic Drug Market, by Drug Class, 2021 & 2030 (USD Billion)
  • Figure 8. Market by Disease
  • Figure 9. Global Ophthalmic Drug Market, by Disease, 2021 & 2030 (USD Billion)
  • Figure 10. Market by Route of Administration
  • Figure 11. Global Ophthalmic Drug Market, by Route of Administration, 2021 & 2030 (USD Billion)
  • Figure 12. Market by Dosage Form
  • Figure 13. Global Ophthalmic Drug Market, by Dosage Form, 2021 & 2030 (USD Billion)
  • Figure 14. Market by Product Type
  • Figure 15. Global Ophthalmic Drug Market, by Product Type, 2021 & 2030 (USD Billion)